One issue has come to divide the state’s legal cannabis industry in recent months: Aspergillus testing. Analytical Cannabis reached out to key figures on both side of the debate to find out why fungi testing has become so fraught.
In an email letter sent last week – seen by Analytical Cannabis – the Department of Cannabis Control (DCC) reminded licensed labs that they are “required to accurately report testing results for cannabis batches.”
The US Department of Health and Human Services (HHS) has recommended that cannabis be reclassified from Schedule I to the less restrictive Schedule III within the Controlled Substance Act.
Cannabis products in Oregon no longer have to be tested for Aspergillus fungi following a suspension order from the Oregon Court of Appeals.
State regulators in Colorado have issued another health and safety notice after “potentially unsafe levels” of total yeast and mold was found in a batch of cannabis flower.
The Missouri Division of Cannabis Regulation has recalled a whopping 62,799 products that weren’t compliantly tracked in the state’s digital trace and trace system.
The participants felt similarly about the safety of second-hand cannabis smoke.
The regulator detected the potential contamination during a routine inspection after reviewing the product’s testing documentation.